Nemiroff Alex's most recent trade in Praxis Precision Medicines Inc was a trade of 768 Common Stock done at an average price of $275.7 . Disclosure was reported to the exchange on Jan. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 275.74 per share. | 12 Jan 2026 | 768 | 25,932 | - | 275.7 | 211,768 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2026 | 6,875 | 27,617 | - | 0 | Common Stock | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 288.45 per share. | 08 Jan 2026 | 917 | 26,700 | - | 288.5 | 264,509 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 292.63 per share. | 07 Jan 2026 | 89 | 20,742 | - | 292.6 | 26,044 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 192.53 per share. | 20 Nov 2025 | 13,339 | 30,908 | - | 192.5 | 2,568,198 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 194.30 per share. | 20 Nov 2025 | 9,100 | 20,831 | - | 194.3 | 1,768,130 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.94 per share. | 20 Nov 2025 | 9,100 | 45,961 | - | 56.9 | 518,154 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 9,100 | 19,717 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 6,230 | 0 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 133.65 per share. | 20 Nov 2025 | 6,230 | 28,775 | - | 133.7 | 832,640 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 5,652 | 2,347 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.40 per share. | 20 Nov 2025 | 5,652 | 36,861 | - | 44.4 | 250,949 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 2,434 | 0 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.40 per share. | 20 Nov 2025 | 2,434 | 31,209 | - | 44.4 | 108,070 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 1,714 | 0 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 190.86 per share. | 20 Nov 2025 | 1,714 | 44,247 | - | 190.9 | 327,139 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.85 per share. | 20 Nov 2025 | 1,714 | 22,545 | - | 83.9 | 143,719 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 193.23 per share. | 20 Nov 2025 | 977 | 29,931 | - | 193.2 | 188,789 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.39 per share. | 12 Feb 2025 | 51 | 20,831 | - | 85.4 | 4,355 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 11,250 | 21,461 | - | 0 | Common Stock | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.15 per share. | 10 Jan 2025 | 579 | 20,882 | - | 63.2 | 36,564 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.52 per share. | 07 Jan 2025 | 89 | 10,211 | - | 77.5 | 6,899 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 80.21 per share. | 14 Nov 2024 | 8,239 | 10,300 | - | 80.2 | 660,827 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 7,583 | 28,817 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.94 per share. | 14 Nov 2024 | 7,583 | 18,540 | - | 56.9 | 431,776 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 36,400 | 36,400 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 7,800 | 10,957 | - | 0 | Common Stock | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.65 per share. | 12 Feb 2024 | 51 | 3,157 | - | 44.6 | 2,277 | Common Stock |
| Praxis Precision Medicines Inc | Nemiroff Alex | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.19 per share. | 07 Jan 2024 | 89 | 3,208 | - | 25.2 | 2,242 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.88 per share. | 12 May 2023 | 11,686 | 49,460 | - | 0.9 | 10,330 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.94 per share. | 12 Feb 2023 | 920 | 37,774 | - | 3.9 | 3,625 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 36,520 | 36,520 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. | 07 Jan 2023 | 1,335 | 38,694 | - | 2.5 | 3,364 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 1.81 per share. | 14 Nov 2022 | 682 | 40,029 | - | 1.8 | 1,235 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Purchase of securities on an exchange or from another person at price $ 1.63 per share. | 13 Jun 2022 | 7,500 | 39,347 | - | 1.6 | 12,225 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 8.80 per share. | 13 May 2022 | 2,202 | 31,847 | - | 8.8 | 19,373 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.85 per share. | 12 Feb 2022 | 755 | 29,645 | - | 12.9 | 9,702 | Common Stock |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 63,000 | 63,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines Inc | Alex Nemiroff | General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 18,000 | 30,400 | - | 0 | Common Stock |